Search Results for

RAIN-3202 (JIT)

A Phase 2 Basket Study of Milademetan in Advanced/Metastatic Solid Tumors

Continue Reading »

---

GY023 (Suspended)

A Randomized Phase II Trial of Triplet Therapy (A PD-L1 Inhibitor Durvalumab (MEDI4736) in Combination with Olaparib and Cediranib) Compared to Olaparib and Cediranib or Durvalumab (MEDI4736) and Cediranib or Standard of Care Chemotherapy in Women with Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Primary Peritoneal or Fallopian Cancer Who Have Received Prior Bevacizumab

Continue Reading »

---

Search Again

• All Trial Categories Amyloidosis  (1) Anal  (1) Bladder/Urinary Tract Cancer  (7)    Adjuvant  (1)    Metastatic  (3)    Neoadjuvant  (1) Brain  (7)    Glioblastoma Multiforme (GBM)  (1)    Other Brain Tumors  (3) Breast  (14)    Breast Cancer Adjuvant  (1)    Breast Cancer Neoadjuvant  (2) Cancer Control/Symptom Management  (21) Carcinoid Tumors  (2) Colorectal Cancer  (7)    Metastatic  (1)    Rectal Neoadjuvant  (1) Esophageal Cancer  (3) Gastric Cancer  (3) Head/Neck Cancer  (8) Leukemia  (1) Lung Cancer  (18)    Non-Small Cell Lung Cancer  (14)       1st Line Metastatic, Stage3b with Maligned Effusion or Stage 4 Disease at Presentation or Recurrence  (2)       Adjuvant Treatment for Resected NSCLC  (2)    Small Cell Lung Cancer  (3)       Extensive Stage SCLC  (1) MATCH Trial  (3) Melanoma  (2) Merkel Cell Carcinoma  (1) Misc. Gynecology  (3) Multiple Myeloma  (2) Ovarian  (2) Pancreatic  (7)    Metastatic Disease  (1) Prostate  (8) Renal Cell/Kidney Cancer  (3)    Locally Advanced/Metastatic  (1) Sarcoma  (1)